Cap-assisted endoscopic sclerotherapy for internal hemorrhoids: technique protocol and study design for a multi-center randomized controlled trial.

Background: Cap-assisted endoscopic sclerotherapy is a new interventional therapy for internal hemorrhoids and rectal prolapse under colonoscopy. The proper length of the endoscopic injection needle is the core for performing cap-assisted endoscopic sclerotherapy well with more benefits and less com...

Descripción completa

Detalles Bibliográficos
Publicado en:Therapeutic Advances in Gastrointestinal Endoscopy pp. 1 - 12
Autores principales: Wu, Xia, Wen, Quan, Cui, Bota, Liu, Yafei, Zhong, Min, Yuan, Yu, Wu, Lihao, Zhang, Xiaoyin, Hu, Yunlian, Lv, Muhan, Wu, Qianneng, He, Suyu, Jin, Yan, Tian, Shuxin, Wan, Rong, Wang, Xin, Xu, Long, Bai, Jianling, Huang, Guangming, Ji, Guozhong
Formato: pictorial protocol tables/charts Journal Article
Publicado: Sage Publications Inc. 6/5/2020
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=143652117&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 143652117
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        26317745
        M8AA
      jtl: Therapeutic Advances in Gastrointestinal Endoscopy
      issn: 26317745
      maglogo: Y
    pubinfo:
      dt: 6/5/2020
      pid: 344
      pub: Sage Publications Inc.
      place: Thousand Oaks, California
    artinfo:
      ui:
        143652117
        143652117
        143652117
        10.1177/2631774520925636
        143652117
      ppf: 1
      ppct: 11
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Cap-assisted endoscopic sclerotherapy for internal hemorrhoids: technique protocol and study design for a multi-center randomized controlled trial.
      aug:
        au:
          Wu, Xia
          Wen, Quan
          Cui, Bota
          Liu, Yafei
          Zhong, Min
          Yuan, Yu
          Wu, Lihao
          Zhang, Xiaoyin
          Hu, Yunlian
          Lv, Muhan
          Wu, Qianneng
          He, Suyu
          Jin, Yan
          Tian, Shuxin
          Wan, Rong
          Wang, Xin
          Xu, Long
          Bai, Jianling
          Huang, Guangming
          Ji, Guozhong
        affil: Medical Center for Digestive Diseases, Second Affiliated Hospital of Nanjing Medical University, Nanjing, China
      sug:
        subj:
          Hemorrhoids Surgery
          Sclerotherapy Methods
          Endoscopy
          Sclerotherapy Equipment and Supplies
          Human
          Randomized Controlled Trials
          Random Assignment
          Multicenter Studies
          Prospective Studies
          Treatment Outcomes
          Data Analysis Software
          Chi Square Test
          Logistic Regression
          Wilcoxon Rank Sum Test
      ab: Background: Cap-assisted endoscopic sclerotherapy is a new interventional therapy for internal hemorrhoids and rectal prolapse under colonoscopy. The proper length of the endoscopic injection needle is the core for performing cap-assisted endoscopic sclerotherapy well with more benefits and less complications. However, no data are currently available to guide endoscopists to consider the length of injection needle before cap-assisted endoscopic sclerotherapy. This study is designed to evaluate the efficacy and safety of cap-assisted endoscopic sclerotherapy with long or short injection needle in the treatment of internal hemorrhoids. Methods: This is a nationwide multi-center, prospective, single-blind and randomized controlled trial. Patients with grade I-II internal hemorrhoids who have failed to conservative treatments and grade III internal hemorrhoids who are not suitable for surgery or refuse surgery will be included. Participants will be randomized 1:1 into either long or short injection needle group. The primary outcome is the recurrence rate of internal hemorrhoids 24 weeks after cap-assisted endoscopic sclerotherapy. The secondary outcomes are as follows: (1) symptom severity score, (2) three-level EuroQoL five dimensions health scale scores, (3) occurrence of adverse events and severe adverse events, and (4) patients' attitudes toward cap-assisted endoscopic sclerotherapy. Data collection will be conducted before and during operation, the 1st day, 1st week, 2nd week, and 24th week after cap-assisted endoscopic sclerotherapy. Discussion: The outcome of this study is expected to provide a practical clinical protocol of cap-assisted endoscopic sclerotherapy for patients with internal hemorrhoids and promote the use of this new endoscopic technique. Trial registration: ClinicalTrials.gov, NCT03917056. Registered on 12 April 2019.
      pubtype: Academic Journal
      doctype:
        pictorial
        protocol
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N